Legal Representation
Attorney
David J. Davis
USPTO Deadlines
Next Deadline
19 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
August 08, 2025
Extension Available
Until August 08, 2024
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 25, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 25, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 24, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 24, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 7, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 7, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 7, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 8, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 13, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 13, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 24, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2023 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 1, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 1, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 1, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 28, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 2, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 2, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 2, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 27, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 9, 2022 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Feb 8, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 6, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jan 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 22, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical additives for use in the manufacture of pharmaceuticals and dietary supplements; active chemical ingredients for use in the manufacture of dietary supplements; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cardiovascular diseases, metabolic diseases, allergies and allergy diseases, arthritis, dermatological diseases, inflammatory diseases, eye diseases, pulmonary diseases, cancer, central nervous system disorders, amyotrophic lateral sclerosis, infectious diseases, gastrointestinal diseases and urologic diseases
Class 005
Pharmaceutical preparations for treating diseases in the nature of cardiovascular diseases, metabolic diseases, allergies and allergy diseases, arthritis, dermatological diseases, inflammatory diseases, eye diseases, pulmonary diseases, cancer, central nervous system disorders, amyotrophic lateral sclerosis, infectious diseases, gastrointestinal diseases and urologic diseases
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CHEMICAL"